BRIEF-Medicines Q3 revenue $37.6 mln versus I/B/E/S view $37.3 mln

* The medicines company reports third-quarter 2016 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.